Back to Trades
Total Value
$226.5K
Net $226.5K sold
Filing Date
Mar 13, 2026
1 transaction
Sales
$226.5K
1 transaction
Trade Summary
On Mar 13, 2026, Mutz Christopher, HEAD OF RARE DISEASE, sold $226.5K of ANI PHARMACEUTICALS INC (ANIP) across 1 transaction. The filing covers Common Stock and reflects net selling of $226.5K. Reported prices ranged from $71.64. Insider transactions are sourced from SEC Form 4 disclosures and should be reviewed alongside company fundamentals and the insider's broader trading history.
Company Information
- Company Name
- ANI PHARMACEUTICALS INC
- Ticker Symbol
- ANIP
- CIK
- 0001023024
Insider Information
- Name
- Mutz Christopher
- Role
- HEAD OF RARE DISEASE
- Location
- BAUDETTE, MN
Filing Details
- Filing Date
- Mar 13, 2026
- Transaction Date
- Mar 13, 2026
- Accession Number
- 0001846487-26-000014
- Form Type
- 4
- Net Trading Amount
- -$226.5K
Non-Derivative Transactions
| Date | Security | Shares | Price | Type | Value |
|---|---|---|---|---|---|
| Mar 13, 2026 | Common Stock | 3,162 | $71.64 | Sale | $226.5K |
Want live alerts when Mutz Christopher trades again?
Download Insider Trades to track ANIP, follow insiders, and get mobile alerts when new SEC Form 4 filings are published.
Footnotes
- (F1)The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 16, 2025.
- (F2)The shares were sold in multiple trades at prices ranging from $70.27 to $72.62. The price reported above reflects the weighted average sales price.